56 Results

People

  1. Mellinghoff
    Mellinghoff
  2. Tabar
    Tabar
  3. Chan
    Chan
  4. Bale
    Bale
  5. Huse
    Huse
  6. Parada
    Parada
  7. Brennan
    Brennan
  8. De Angelis
    De Angelis
  9. Donzelli
    Donzelli
  10. Souweidane
    Souweidane

Groups

  1. Sloan Kettering Institute Postdocs (56)
  2. GSK Faculty (45)
  3. Tow Center for Developmental Oncology (TCDO) (23)
  4. Human Oncology and Pathogenesis Program (18)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  6. Sloan Kettering Institute Faculty (16)
  7. Radiology, Department of (12)
  8. Cancer Biology and Genetics Program Faculty (9)
  9. Pediatrics, Department of (9)
  10. Center for Pancreatic Cancer Research (8)
  1. "Meeting abstract"
  2. "Sloan Kettering Institute Postdocs"
  3. "Neuro-Oncology"
Formats
  1. Meeting Abstract (56)
Groups
  1. Sloan Kettering Institute Postdocs (56)
  2. GSK Faculty (45)
  3. Tow Center for Developmental Oncology (TCDO) (23)
  4. Human Oncology and Pathogenesis Program (18)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  6. Sloan Kettering Institute Faculty (16)

More Groups

People
  1. Ingo Mellinghoff (9)
  2. Viviane Tabar (9)
  3. Tejus Bale (8)
  4. Timothy Chan (7)
  5. Jason Huse (6)
  6. Luis Parada (6)

More People

Years
  1. 2023 (8)
  2. 2022 (5)
  3. 2021 (4)
  4. 2020 (3)
  5. 2019 (5)
  6. 2018 (10)

More Years

Publications
  1. Neuro-Oncology (56)
Publishers
  1. Oxford University Press (56)

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
    Meeting Abstract

    Venneti, S.; Kawakibi, A. R.; Ji, S.; Waszak, S.; Sweha, S.; Mota, M.; Pun, M.; Deogharkar, A.; Chung, C.; Tarapore, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Droplet digital PCR enhances detection of hotspot mutations in circulating tumor DNA from cerebrospinal fluid of patients with high-grade glioma
    Meeting Abstract

    Tartaro, M.; Nandakumar, S.; Hertz, C. A.; Holle, B.; Hill, K.; Lapshina, M.; Farina, A.; Arcila, M.; Miller, A.; Mellinghoff, I.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Modeling reversible tumorigenesis in cerebral organoids
    Meeting Abstract

    Graham, M.; Codega, P.; Campos, C.; Nandakumar, S.; Rosenblum, M.; Antonescu, C.; Grogan, M.; Benhamida, J.; Bale, T.; von Deimling, A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • The genomic landscape of brain metastasis
    Meeting Abstract

    Skakodub, A.; Walch, H.; Kumar, R.; Eichholz, J.; Cooper, C.; Khatri, I.; Del Balzo, L.; Miao, E.; Gui, C.; Ma, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Loss of micrornas cooperates with tumor suppressors to initiate MYC-dependent metastatic medulloblastoma
    Meeting Abstract

    Llaguno, S. A.; Nazarenko, I.; Chen, Y.; Sun, D.; Gudenas, B.; Saulnier, O.; La Rocca, G.; Pedraza, A.; Burns, D.; Bale, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of brainstem gliomas in pediatric, adolescent, and young adult patients through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B.; Alano, T.; Doe-Tetteh, S.; Bouvier, N.; Li, S.; Stockfisch, E.; Huereca, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A novel oncogenic role for menin in glioma
    Meeting Abstract

    Yang, Y.; Saito, Y.; Goldberg, E.; Abou Mrad, Z.; Larsen, A. G.; Ghita, G.; Tabar, V.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Tractable patient-derived models for preclinical therapeutic studies of CNS metastases
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Offin, M. D.; Lui, A. J. W.; Khodos, I.; Chang, Q.; Mattar, M. S.; De Stanchina, E.; Ladanyi, M.; Somwar, R.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy data on two patients with relapsed/refractory CNS lymphoma treated with emavusertib (CA-4948) and ibrutinib combination: A subset analysis of TakeAim Lymphoma trial
    Meeting Abstract

    Iqbal, M.; Tun, H.; Joffe, E.; Grommes, C.; Nowakowski, G.; Lunning, M.; Ramchandren, R.; Li, C. C.; Zhao, W.; Martinez, E.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save